Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IV Oseltamivir for Influenza
NCT01050257Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of oseltamivir in influenza, sponsored by Roche. Started Jan 2010; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01050257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050257.